Published in Virology on February 01, 1983
Trans activation of transcription by herpes virus products: requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J (1984) 7.33
Structural analysis of the major immediate early gene of human cytomegalovirus. J Virol (1984) 6.67
Activation of the major immediate early gene of human cytomegalovirus by cis-acting elements in the promoter-regulatory sequence and by virus-specific trans-acting components. J Virol (1985) 5.47
Multiple spliced and unspliced transcripts from human cytomegalovirus immediate-early region 2 and evidence for a common initiation site within immediate-early region 1. J Virol (1985) 5.09
Promoter-regulatory region of the major immediate early gene of human cytomegalovirus. Proc Natl Acad Sci U S A (1984) 5.04
Regulation of cytomegalovirus gene expression: alpha and beta promoters are trans activated by viral functions in permissive human fibroblasts. J Virol (1985) 4.39
Identification and characterization of the human cytomegalovirus immediate-early region 2 gene that stimulates gene expression from an inducible promoter. J Virol (1987) 4.33
Promoter-specific trans activation and repression by human cytomegalovirus immediate-early proteins involves common and unique protein domains. J Virol (1990) 4.24
Transactivation of a human cytomegalovirus early promoter by gene products from the immediate-early gene IE2 and augmentation by IE1: mutational analysis of the viral proteins. J Virol (1990) 4.01
Use of differential display analysis to assess the effect of human cytomegalovirus infection on the accumulation of cellular RNAs: induction of interferon-responsive RNAs. Proc Natl Acad Sci U S A (1997) 3.25
Predominant immediate-early transcripts of human cytomegalovirus AD 169. J Virol (1984) 3.15
Autoregulation of the human cytomegalovirus major immediate-early gene. J Virol (1985) 2.91
Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J Virol (1988) 2.90
Binding of transcription factors and creation of a large nucleoprotein complex on the human cytomegalovirus enhancer. Proc Natl Acad Sci U S A (1987) 2.89
Regulation of cytomegalovirus late gene expression: gamma genes are controlled by posttranscriptional events. J Virol (1986) 2.84
DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J Virol (1999) 2.80
Human cytomegalovirus US3 and UL36-38 immediate-early proteins regulate gene expression. J Virol (1992) 2.72
A human cytomegalovirus early gene has three inducible promoters that are regulated differentially at various times after infection. J Virol (1989) 2.70
UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol (1994) 2.69
Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. J Virol (1989) 2.68
Temporal regulation of murine cytomegalovirus transcription and mapping of viral RNA synthesized at immediate early times after infection. J Virol (1984) 2.62
Nuclear factor 1 interacts with five DNA elements in the promoter region of the human cytomegalovirus major immediate early gene. EMBO J (1986) 2.62
Translational control of cytomegalovirus gene expression is mediated by upstream AUG codons. J Virol (1988) 2.35
The promoter-regulatory region of the major immediate-early gene of human cytomegalovirus responds to T-lymphocyte stimulation and contains functional cyclic AMP-response elements. J Virol (1989) 2.32
Human cytomegalovirus immediate-early two protein region involved in negative regulation of the major immediate-early promoter. J Virol (1990) 2.28
Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169. J Virol (1985) 2.15
Transcriptional regulation of the human cytomegalovirus major immediate-early gene is associated with induction of DNase I-hypersensitive sites. Mol Cell Biol (1986) 2.05
Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J Virol (1994) 1.94
2.2-kilobase class of early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD169. J Virol (1986) 1.91
Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol (2000) 1.91
Translational control of human cytomegalovirus gp48 expression. J Virol (1991) 1.90
Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol (1995) 1.85
Regulation of cytomegalovirus late-gene expression: differential use of three start sites in the transcriptional activation of ICP36 gene expression. J Virol (1989) 1.83
Functional interaction between the pp71 protein of human cytomegalovirus and the PML-interacting protein human Daxx. J Virol (2002) 1.83
Human cytomegalovirus UL36-38 and US3 immediate-early genes: temporally regulated expression of nuclear, cytoplasmic, and polysome-associated transcripts during infection. J Virol (1991) 1.81
Expression of a human cytomegalovirus late gene is posttranscriptionally regulated by a 3'-end-processing event occurring exclusively late after infection. Mol Cell Biol (1986) 1.78
A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J Virol (1996) 1.74
Fine mapping of transcripts expressed from the US6 gene family of human cytomegalovirus strain AD169. J Virol (1991) 1.70
Protein-protein interactions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J Virol (1994) 1.62
Multiple regulatory events influence human cytomegalovirus DNA polymerase (UL54) expression during viral infection. J Virol (1996) 1.60
Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene. J Virol (1989) 1.57
Open reading frame UL26 of human cytomegalovirus encodes a novel tegument protein that contains a strong transcriptional activation domain. J Virol (2002) 1.57
Mapping and expression of a human cytomegalovirus major viral protein. J Virol (1984) 1.55
The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations. J Virol (1995) 1.52
Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus. J Virol (1993) 1.51
Precise localization of genes on large animal virus genomes: use of lambda gt11 and monoclonal antibodies to map the gene for a cytomegalovirus protein family. Proc Natl Acad Sci U S A (1985) 1.50
Discordant expression of the immediate-early 1 and 2 gene regions of human cytomegalovirus at early times after infection involves posttranscriptional processing events. J Virol (1991) 1.48
Modulation of interleukin 1 beta gene expression by the immediate early genes of human cytomegalovirus. J Clin Invest (1990) 1.46
Replication of human cytomegalovirus in human peripheral blood T cells. J Virol (1986) 1.45
Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit. J Virol (1989) 1.45
Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169. J Virol (1988) 1.44
Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter. J Virol (1994) 1.44
Identification of sequence elements in the human cytomegalovirus DNA polymerase gene promoter required for activation by viral gene products. J Virol (1994) 1.43
CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol (1996) 1.43
Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6. J Virol (2000) 1.41
Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol (1998) 1.41
Antisense transcription in the human cytomegalovirus transcriptome. J Virol (2007) 1.40
A multigene family encodes the human cytomegalovirus glycoprotein complex gcII (gp47-52 complex). J Virol (1988) 1.36
Structure of the transforming region of human cytomegalovirus AD169. J Virol (1984) 1.35
An inducible promoter mediates abundant expression from the immediate-early 2 gene region of human cytomegalovirus at late times after infection. J Virol (1991) 1.33
Functional analysis of the true late human cytomegalovirus pp28 upstream promoter: cis-acting elements and viral trans-acting proteins necessary for promoter activation. J Virol (1992) 1.31
The human cytomegalovirus 86-kilodalton major immediate-early protein interacts physically and functionally with histone acetyltransferase P/CAF. J Virol (2000) 1.28
Deletion of open reading frame UL26 from the human cytomegalovirus genome results in reduced viral growth, which involves impaired stability of viral particles. J Virol (2006) 1.25
An AP-1 binding site is the predominant cis-acting regulatory element in the 1.2-kilobase early RNA promoter of human cytomegalovirus. J Virol (1992) 1.24
The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor. J Virol (1990) 1.24
Use of recombinant virus to assess human cytomegalovirus early and late promoters in the context of the viral genome. J Virol (1994) 1.24
Establishment of a rat cell line inducible for the expression of human cytomegalovirus immediate-early gene products by protein synthesis inhibition. J Virol (1986) 1.23
Regulation of a human cytomegalovirus immediate-early gene (US3) by a silencer-enhancer combination. J Virol (1996) 1.13
Minor groove contacts are essential for an interaction of the human cytomegalovirus IE2 protein with its DNA target. Nucleic Acids Res (1994) 1.11
Characterization of the guinea pig cytomegalovirus genome by molecular cloning and physical mapping. J Virol (1984) 1.10
Regulation of human cytomegalovirus US3 gene transcription by a cis-repressive sequence. J Virol (1995) 1.07
Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J Virol (1998) 1.05
Isolation and characterization of a low-abundance splice variant from the human cytomegalovirus major immediate-early gene region. J Virol (1995) 1.05
Analysis of a region of the human cytomegalovirus (AD169) genome coding for a 25-kilodalton virion protein. J Virol (1989) 1.04
The human cytomegalovirus UL98 gene transcription unit overlaps with the pp28 true late gene (UL99) and encodes a 58-kilodalton early protein. J Virol (1995) 1.02
Characterization of a human cytomegalovirus 1.6-kilobase late mRNA and identification of its putative protein product. J Virol (1991) 1.00
Binding of cellular repressor protein or the IE2 protein to a cis-acting negative regulatory element upstream of a human cytomegalovirus early promoter. J Virol (1995) 1.00
The human cytomegalovirus 86-kilodalton immediate-early 2 protein: synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin. J Virol (1994) 0.99
Recruitment of human cytomegalovirus immediate-early 2 protein onto parental viral genomes in association with ND10 in live-infected cells. J Virol (2007) 0.99
Binding of SP1 to the immediate-early protein-responsive element of the human cytomegalovirus DNA polymerase promoter. J Virol (1997) 0.98
Cell-related sequences in the DNA genome of human cytomegalovirus strain AD169. J Virol (1985) 0.94
Isolation and characterization of phosphonoacetic acid-resistant mutants of human cytomegalovirus. J Virol (1987) 0.92
Importance of covalent and noncovalent SUMO interactions with the major human cytomegalovirus transactivator IE2p86 for viral infection. J Virol (2009) 0.91
Acquisition of cytomegalovirus infection: an update. Clin Microbiol Rev (1989) 0.91
Transcriptional analysis of the eight-kilobase mRNA encoding the major capsid protein of human cytomegalovirus. J Virol (1990) 0.89
Insertion of an EYFP-pp71 (UL82) coding sequence into the human cytomegalovirus genome results in a recombinant virus with enhanced viral growth. J Virol (2008) 0.89
Immediate-early transcription of Herpesvirus saimiri. J Virol (1984) 0.87
Characterization of guinea pig cytomegalovirus DNA. J Virol (1984) 0.86
The major open reading frame of the beta2.7 transcript of human cytomegalovirus: in vitro expression of a protein posttranscriptionally regulated by the 5' region. J Virol (1998) 0.86
Human cytomegalovirus: taking the strain. Med Microbiol Immunol (2015) 0.84
The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line. Virology (2015) 0.76
Proviruses of avian sarcoma virus are terminally redundant, co-extensive with unintegrated linear DNA and integrated at many sites. Cell (1978) 7.46
Nucleotide sequences related to the transforming gene of avian sarcoma virus are present in DNA of uninfected vertebrates. Proc Natl Acad Sci U S A (1978) 4.47
Polyadenylic acid on poliovirus RNA. II. poly(A) on intracellular RNAs. J Virol (1975) 3.65
Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol (1995) 3.18
Detection of human cytomegalovirus in clinical specimens by DNA-DNA hybridization. J Infect Dis (1984) 3.10
Identification of sequence requirements and trans-acting functions necessary for regulated expression of a human cytomegalovirus early gene. J Virol (1988) 2.90
Requirement of 3'-terminal poly(adenylic acid) for the infectivity of poliovirus RNA. Proc Natl Acad Sci U S A (1974) 2.89
Human immunodeficiency virus infection of human-PBL-SCID mice. Science (1991) 2.77
Cleavage maps for human cytomegalovirus DNA strain AD169 for restriction endonucleases EcoRI, BglII, and HindIII. J Virol (1982) 2.59
Construction of a cloned library of the EcoRI fragments from the human cytomegalovirus genome (strain AD169). J Virol (1982) 2.52
Characteristics of cellular RNA related to the transforming gene of avian sarcoma viruses. Cell (1978) 2.50
Is the learn unit a fundamental measure of pedagogy? Behav Anal (1999) 2.31
Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol (1998) 2.18
Analysis of the major transcripts encoded by the long repeat of human cytomegalovirus strain AD169. J Virol (1985) 2.15
In vivo and in vitro analysis of transcriptional activation mediated by the human cytomegalovirus major immediate-early proteins. Mol Cell Biol (1993) 2.11
Uninfected avian cells contain RNA related to the transforming gene of avian sarcoma viruses. Cell (1978) 2.10
Molecular cloning and restriction endonuclease mapping of the murine cytomegalovirus genome (Smith Strain). Virology (1983) 2.06
Transactivation by the human cytomegalovirus IE2 86-kilodalton protein requires a domain that binds to both the TATA box-binding protein and the retinoblastoma protein. J Virol (1994) 1.94
2.2-kilobase class of early transcripts encoded by cell-related sequences in human cytomegalovirus strain AD169. J Virol (1986) 1.91
Pathogenesis of murine cytomegalovirus infection: identification of infected cells in the spleen during acute and latent infections. J Virol (1988) 1.83
Enzymatic amplification of human cytomegalovirus sequences by polymerase chain reaction. J Clin Microbiol (1989) 1.81
Exploitation of cellular signaling and regulatory pathways by human cytomegalovirus. Trends Microbiol (2000) 1.81
Structure of the heterogeneous L-S junction region of human cytomegalovirus strain AD169 DNA. J Virol (1984) 1.73
Sequences in the human cytomegalovirus 2.7-kilobase RNA promoter which mediate its regulation as an early gene. J Virol (1989) 1.57
p53 and RPA are sequestered in viral replication centers in the nuclei of cells infected with human cytomegalovirus. J Virol (1998) 1.57
The human cytomegalovirus IE2 86-kilodalton protein interacts with an early gene promoter via site-specific DNA binding and protein-protein associations. J Virol (1995) 1.52
Polyadenylic acid on poliovirus RNA IV. Poly(U) in replicative intermediate and double-stranded RNA. Virology (1975) 1.51
Post-transcriptional control of avian oncornavirus transforming gene sequences in mammalian cells. Nature (1977) 1.48
Highly sensitive multiplex assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA. J Clin Microbiol (2002) 1.46
Posttranscriptional regulation of a class of human cytomegalovirus phosphoproteins encoded by an early transcription unit. J Virol (1989) 1.45
Four phosphoproteins with common amino termini are encoded by human cytomegalovirus AD169. J Virol (1988) 1.44
Site-specific binding of the human cytomegalovirus IE2 86-kilodalton protein to an early gene promoter. J Virol (1994) 1.44
CREB and CREB-binding proteins play an important role in the IE2 86-kilodalton protein-mediated transactivation of the human cytomegalovirus 2.2-kilobase RNA promoter. J Virol (1996) 1.43
Terminal structure and heterogeneity in human cytomegalovirus strain AD169. J Virol (1986) 1.42
Extracellular signal-regulated kinase activity is sustained early during human cytomegalovirus infection. J Virol (1998) 1.41
Transcription analysis and sequence of the putative murine cytomegalovirus DNA polymerase gene. Virology (1991) 1.33
Rapid and quantitative detection of enzymatically amplified HIV-1 DNA using chemiluminescent oligonucleotide probes. AIDS Res Hum Retroviruses (1990) 1.33
Transcription in mouse embryo cells permissively infected by murine cytomegalovirus. Virology (1983) 1.30
An AP-1 binding site is the predominant cis-acting regulatory element in the 1.2-kilobase early RNA promoter of human cytomegalovirus. J Virol (1992) 1.24
The human cytomegalovirus 2.7-kilobase RNA promoter contains a functional binding site for the adenovirus major late transcription factor. J Virol (1990) 1.24
DNA immunization confers protection against murine cytomegalovirus infection. J Virol (1996) 1.22
Regenerating adult chicken skeletal muscle and satellite cell cultures express embryonic patterns of myosin and tropomyosin isoforms. Dev Biol (1983) 1.21
Specific chromosome 1 breaks induced by human cytomegalovirus. Proc Natl Acad Sci U S A (2000) 1.21
Suppression of murine cytomegalovirus (MCMV) replication with a DNA vaccine encoding MCMV M84 (a homolog of human cytomegalovirus pp65). J Virol (2000) 1.16
Pathogenesis of acute murine cytomegalovirus infection in resistant and susceptible strains of mice. J Virol (1986) 1.11
Polyadenylic acid on poliovirus RNA. III. In vitro addition of polyadenylic acid to poliovirus RNAs. J Virol (1975) 1.09
Subversion of cell cycle regulatory pathways. Curr Top Microbiol Immunol (2008) 1.09
Replication of the murine cytomegalovirus genome: structure and role of the termini in the generation and cleavage of concatenates. Virology (1988) 1.08
The effects of cytomegalovirus on human immunodeficiency virus replication in brain-derived cells correlate with permissiveness of the cells for each virus. J Virol (1994) 1.08
Studies on the function of polyadenylic acid on poliovirus RNA. Cell (1975) 1.07
Separate DNA elements containing ATF/CREB and IE86 binding sites differentially regulate the human cytomegalovirus UL112-113 promoter at early and late times in the infection. J Virol (1998) 1.05
Human cytomegalovirus-mediated enhancement of human immunodeficiency virus type-1 production in monocyte-derived macrophages. Virology (1994) 1.05
The use of DNA probes in studies of human cytomegalovirus. Clin Chem (1985) 1.04
Regulation of human cytomegalovirus gene expression. Adv Virus Res (1999) 1.04
Cloning, characterization, and expression of the murine cytomegalovirus homologue of the human cytomegalovirus 28-kDa matrix phosphoprotein (UL99). Virology (1994) 1.01
The oncogenic potential of human cytomegalovirus. Prog Med Virol (1984) 1.01
Fusion of the termini of the murine cytomegalovirus genome after infection. J Virol (1984) 0.98
Human cytomegalovirus (strain AD169) contains sequences related to the avian retrovirus oncogene v-myc. Proc Natl Acad Sci U S A (1983) 0.98
Sequences in human cytomegalovirus which hybridize with the avian retrovirus oncogene v-myc are G + C rich and do not hybridize with the human c-myc gene. Mol Cell Biol (1985) 0.98
Development of dopaminergic neurons in the human substantia nigra. Exp Neurol (1991) 0.96
Cell-related sequences in the DNA genome of human cytomegalovirus strain AD169. J Virol (1985) 0.94
Human cytomegalovirus inhibits human immunodeficiency virus replication in cells productively infected by both viruses. J Virol (1991) 0.93
Poly(A) on mengovirus RNA. J Virol (1975) 0.90
Genesis of a virus-transforming gene. Natl Cancer Inst Monogr (1978) 0.89
Use of molecular probes to detect human cytomegalovirus and human immunodeficiency virus. Clin Chem (1989) 0.89
Molecular epidemiology of cytomegalovirus infections in premature twin infants and their mother. Pediatr Infect Dis (1983) 0.87
Differential effects of human cytomegalovirus on integrated and unintegrated human immunodeficiency virus sequences. J Virol (1995) 0.85
The use of recombinant baculoviruses for sustained expression of human cytomegalovirus immediate early proteins in fibroblasts. Virology (2001) 0.82
Streptomycin retards the phenotypic maturation of chick myogenic cells. In Vitro (1984) 0.78
Molecular analysis of the differential restriction of human immunodeficiency virus type 1 replication in neuronal cell lines. J Gen Virol (1997) 0.78
A model system for human cytomegalovirus-mediated modulation of human immunodeficiency virus type 1 long terminal repeat activity in brain cells. J Virol (1997) 0.77
Construction of single amino acid substitution mutants of cloned Bacillus stearothermophilus DNA polymerase I which lack 5'-->3' exonuclease activity. Biochim Biophys Acta (1996) 0.77
The molecular biology of poliovirus. Sci Am (1975) 0.76
Gene-specific probes for avian retroviruses. Curr Top Microbiol Immunol (1981) 0.75